Skip to content

Xcela 44032Recalls & reported problems

Navilyst Medical, Inc. · Xcela Plus Plastic Port with Filled Suture Holes and 8F x 63cm Polyurethane Catheter · Class 2 · Implant

All models of Xcela (39)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H965440320), received between Jul 17, 2024 and Mar 10, 2025 — classified as 2 injuries, 1 malfunction.

The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 2 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Fluid/Blood Leak1
  • Insufficient Device Problem Information1

Patient problems

  • Bacterial Infection1
  • Failure of Implant1
  • Fever1
  • Infiltration into Tissue1
  • Unspecified Infection1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryMar 10, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    ON OR ABOUT ON (B)(6) 2021, PLAINTIFF UNDERWENT PLACEMENT OF AN ANGIODYNAMICS VORTEX IMPLANTABLE PORT, MODEL NUMBER: H787P5455K0, LOT NUMBER: 5670753. THE DEVICE WAS IMPLANTED BY DR. (B)(6), M.D., AT (B)(6), TO FACILITATE CHEMOTHERAPY TREATMENT. ON OR ABOUT ON (B)(6) 2023, PLAINTIFF PRESENTED TO (B)(6), WITH COMPLAINTS OF A FEVER. ON OR ABOUT ON (B)(6) 2023, PLAINTIFF RECEIVED A CALL FROM HER DOCTOR THAT HER BLOOD CULTURES DRAWN ON (B)(6) 2023, CAME BACK POSITIVE FOR A BACTERIAL INFECTION, AND THAT SHE NEEDS TO GO TO THE EMERGENCY ROOM. ON OR ABOUT ON (B)(6) 2023, PLAINTIFF PRESENTED TO THE EMERGENCY ROOM AT (B)(6), FOR FURTHER EVALUATION AS DIRECTED BY HER DOCTOR. AFTER EVALUATION, PLAINTIFF'S MEDICAL TEAM DETERMINED THAT THE VORTEX WAS THE SOURCE OF THE INFECTION AND THAT THE IMPLANT NEEDED TO BE REMOVED. ON OR ABOUT ON (B)(6) 2023, DUE TO HER INFECTED VORTEX PORT CATHETER, PLAINTIFF UNDERWENT SURGICAL REMOVAL OF THE DEFECTIVE DEVICE, WHICH WAS REMOVED BY (B)(6), M.D., AT (B)(6).

    Patient problems: Bacterial Infection; Fever

    MAUDE report 21560507 ↗
  • InjuryMar 10, 2025Insufficient Device Problem Information; Insufficient Device Problem Information

    ON OR ABOUT (B)(6) 2022, PLAINTIFF UNDERWENT PLACEMENT OF THE ANGIODYNAMICS SMARTPORT POWER INJECTABLE PORT, REFERENCE NUMBER (B)(4), LOT NUMBER 5737583. THE DEVICE WAS IMPLANTED BY (B)(6), MD, AT (B)(6), FOR THE PURPOSE OF ONGOING VEIN ACCESS. ON OR ABOUT (B)(6) 2023, PLAINTIFF PRESENTED HERSELF TO (B)(6) WHERE HER PORT WAS SUBSEQUENTLY REMOVED DUE TO MALFUNCTIONING AND AN INFECTION.

    Patient problems: Unspecified Infection

    MAUDE report 21559745 ↗
  • MalfunctionJul 17, 2024Fluid/Blood Leak; Fluid/Blood Leak

    AN END USER REPORTED AN ISSUE WITH AN XCELA, 8F SINGLE PLASTIC PORT FILLED NON-VALVED. DURING CHEMOTHERAPY TREATMENT, THE PORT WAS INFILTRATED AND LEAKED WITHIN THE PATIENT. THE PATIENT HAD A PORT REMOVAL PROCEDURE SCHEDULED FOR (B)(6) 2024. DESPITE MULTIPLE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL DETAILS, NO FURTHER INFORMATION HAS BEEN RECEIVED.

    Patient problems: Failure of Implant; Infiltration into Tissue

    MAUDE report 19762788 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page